Furthermore, different CD4+ and CD8+ T cell subsets are associated with specific outcomes in both infectious diseases and immune disorders [17,24], which implies that the T cell phenotype, in addition to the number of circulating CD4+ T cells, is crucial in determining the outcome of CM. This evidence concerns the gene CD4 and immune system disorder.